Viromed Company Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Viromed Company Ltd with three other
pharmaceutical manufacturers in Asia:
Mycenax Biotech Incorporated
sales of 200.61 million Taiwanese Dollars [US$6.58 million]
of which 100%
was Biological Medicine),
China Regenerative Medicine International Ltd
of Hong Kong
(27.75 million Hong Kong Dollars [US$3.57 million]
of which 73%
was Cosmetic and Health Products), and
(6.84 billion Korean Won [US$6.09 million]
During the year ended December of 2016, sales at
Viromed Company Ltd were 6.84 billion Korean Won (US$6.09 million).
decrease of 11.1%
versus 2015, when the company's sales were 7.70 billion Korean Won.